Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury.

Journal of Neuroscience Research
Samir P PatelAlexander G Rabchevsky

Abstract

We recently documented the progressive nature of mitochondrial dysfunction over 24 hr after contusion spinal cord injury (SCI), but the underlying mechanism has not been elucidated. We investigated the effects of targeting two distinct possible mechanisms of mitochondrial dysfunction by using the mitochondrial uncoupler 2,4-dinitrophenol (2,4-DNP) or the nitroxide antioxidant Tempol after contusion SCI in rats. A novel aspect of this study was that all assessments were made in both synaptosomal (neuronal)- and nonsynaptosomal (glial and neuronal soma)-derived mitochondria 24 hr after injury. Mitochondrial uncouplers target Ca(2+) cycling and subsequent reactive oxygen species production in mitochondria after injury. When 2,4-DNP was injected 15 and 30 min after injury, mitochondrial function was preserved in both populations compared with vehicle-treated rats, whereas 1 hr postinjury treatment was ineffective. Conversely, targeting peroxynitrite with Tempol failed to maintain normal bioenergetics in synaptic mitochondria, but was effective in nonsynaptic mitochondria when administered 15 min after injury. When administered at 15 and 30 min after injury, increased hydroxynonenal, 3-NT, and protein carbonyl levels were significan...Continue Reading

References

Jun 1, 1993·Annals of Emergency Medicine·D K Anderson, E D Hall
Apr 16, 1998·Biochimica Et Biophysica Acta·V P Skulachev
Aug 26, 1998·Biochimica Et Biophysica Acta·D G Nicholls, S L Budd
Jan 23, 1999·BioFactors·D G Nicholls, S L Budd
Apr 10, 1999·Nature Neuroscience·A K StoutI J Reynolds
Oct 18, 2002·Neuroscience Letters·Nickolay BrustovetskyJanet M Dubinsky
Jun 5, 2003·Annals of Neurology·Patrick G SullivanTallie Z Baram
Apr 2, 2004·Neurobiology of Disease·Christos ProfyrisSteven Petratos
Jun 3, 2004·The Journal of Comparative Neurology·Patrick G SullivanStephen W Scheff
Sep 21, 2004·Journal of Bioenergetics and Biomembranes·P G SullivanStephen W Scheff
Sep 28, 2004·Journal of Neurochemistry·William F Maragos, Amit S Korde
Dec 2, 2004·Journal of Neuroscience Research·P G SullivanJ E Springer
Aug 27, 2005·Mitochondrion·Jonathan LifshitzTracy K McIntosh
Mar 7, 2006·The Journal of Biological Chemistry·Maile R BrownJames W Geddes
Jun 21, 2006·Journal of Bioenergetics and Biomembranes·Linda L BambrickGary Fiskum
Jan 12, 2007·American Journal of Physiology. Cell Physiology·Marko LjubkovicMartin Bienengraeber
Jun 30, 2007·Journal of Neurotrauma·Patrick G SullivanAlexander G Rabchevsky
Jul 13, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kranthi Kumari NagaJames W Geddes

❮ Previous
Next ❯

Citations

Jan 29, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Hong-Hua QuanMing Li
Mar 2, 2011·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Melanie L McEwenJoe E Springer
Mar 11, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mary L Garcia-CazarinFrancisco H Andrade
Nov 13, 2013·ASN Neuro·Shweta Mandrekar-ColucciDana M McTigue
Apr 17, 2013·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Alexis F WelkerMarcelo Hermes-Lima
Mar 7, 2014·Archives of Environmental Contamination and Toxicology·Saba ShamimMahmood Hussain Qazi
Jan 14, 2016·Redox Biology·Nishant P VisavadiyaAlexander G Rabchevsky
Jan 7, 2015·Experimental Neurology·Wang-Xia WangJoe E Springer
May 25, 2011·Pharmacology & Therapeutics·Alexander G RabchevskyJoe E Springer
Jan 19, 2010·Mechanisms of Ageing and Development·Lesley K GilmerStephen W Scheff
May 25, 2016·Revista Brasileira De Ortopedia·Renato Carlos do Vale Ramos, Nuno Alegrete
May 5, 2016·Neurobiology of Aging·Jignesh D PandyaPrasada Rao S Kodavanti
May 5, 2010·Journal of Neurochemistry·Samir P PatelAlexander G Rabchevsky
Nov 20, 2009·Journal of Neurochemistry·Mei LiuGuoying Bing
Dec 27, 2012·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Nishant P VisavadiyaJoe E Springer
Dec 5, 2014·Journal of Bioenergetics and Biomembranes·Heather M YonutasPatrick G Sullivan
Jun 21, 2016·Progress in Neurobiology·P Benson Ham, Raghavan Raju
Sep 24, 2015·PloS One·Helen P McWilliams-KoeppenJonathan S Wall
Jun 11, 2009·Free Radical Research·Yiqin XiongEdward D Hall
Sep 25, 2017·The Journal of Pharmacology and Experimental Therapeutics·Natalie E Scholpa, Rick G Schnellmann
Jun 28, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Liang WuHechun Xia
Sep 12, 2009·Critical Reviews in Toxicology·Helmut GreimHeinz-Walter Thielmann
Jan 11, 2021·Experimental Neurology·Andrew N StewartJohn C Gensel
May 1, 2020·Experimental Neurology·Alexander G RabchevskySamir P Patel
Jun 22, 2021·Frontiers in Molecular Neuroscience·Joseph KedraGeorge M Smith
Apr 27, 2010·Tetrahedron·Caroline QuinRichard C Hartley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Melanie L McEwenJ E Springer
© 2022 Meta ULC. All rights reserved